IL17A and dry eye syndrome: By treating epidermal KCs with the key pro-inflammatory cytokines associated with the disease, such as IL-17A, IL-22, IFN-γ, and TNF-α [3], we intended to mimic the effects induced by the corresponding immune cells, which are not present in the KCs in vitro models.